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Abstract
Objectives: Fetal growth and rapid postnatal weight gain are associated with adverse
respiratory outcomes in childhood. However, the preterm-born population is less well
studied. We assessed if the increased respiratory symptoms associated with altered
fetal growth and infant weight gain were mediated by early factors.
Study Design:Weused data from our cohort of preterm- and term-born (n = 4284 and
2865) children, aged 1-10 years. Respiratory outcomes obtained from a respiratory
questionnaire were regressed on measures of fetal growth and infant weight gain,
defined as >0.67 SD change in fetal measurement or weight between birth and nine
months of age, then adjusted for covariates.We usedmediation analysis to investigate
which variables were effect modifiers.
Results: Accelerated fetal growth between the 1st trimester and birth (OR 2.01;
95%CI 1.25, 2.32), and between the 2nd trimester and birth (1.60; 1.15, 2.22) was
associated with increased wheeze-ever in preterm-born children. Rapid infant
weight gain was associated with increased wheeze-ever (1.22; 1.02, 1.45);
children born ≤32 weeks’ gestation exhibiting rapid weight gain had fivefold
higher risk of wheeze-ever compared to term-born without weight gain. Current
maternal smoking and gestational age were identified as candidate mediating
effects.
Conclusions: Our study suggested that antenatal and postnatal growth rates are
important for future respiratory health in preterm-born children, and that their effects
may be mediated by modifiable factors. Minimizing exposure to environmental
pollutants, especially maternal tobacco smoking, may improve outcomes.
K E YWORD S
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1 | INTRODUCTION
Preterm-born (<37 weeks’ gestation) children are at an increased risk
of respiratory symptoms, hospital admissions and reduced lung
function in childhood and beyond.1–3 These risks persist into
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adulthood potentially developing into early-onset chronic obstructive
pulmonary disease.1,4
Recently there has been interest in both antenatal and postnatal
growth patterns in children, and how these relate to risk of childhood
respiratory disease. Historically, birthweight has been used a proxy for
fetal wellbeing; however, it is recognized that satisfactory birth weight
results from months of development during which the fetus may be
exposed to adverse intrauterine condition.5,6 Adaptation to this
adversity affects the development of organ systems,7 such as the
respiratory system,which continues to develop throughout gestation.8
Dysregulation of lung growth may be further compounded by preterm
birth9 and pulmonary inflammation associated with neonatal respira-
tory distress.10 To date, the few studies investigating the association of
fetal growth patterns with later childhood respiratory disease have
reported inconsistent results.11–14
Early infant growth is also linked to increased respiratory sequelae
in childhood. However, studies have focused largely on term-born
populations.15–19 A recentmeta-analysis of 147 000 children including
7384 preterm-born individuals noted an association between greater
weight gain in the first year of life and increased childhood asthma.20
Further exploration of 24 938 children (2053 born preterm) noted an
association between gestational age, infant weight gain, and measures
of lung function.21 However, both studies included preterm-born
subjects who were recruited in largely term-born cohorts, thus
suggesting selection bias. Moreover, previous studies have reported
only associations and have not explored the important early life factors
that may influence the effect of fetal growth trajectories and postnatal
weight gain on respiratory outcomes.
In this study, we investigated the association of fetal growth
parameters and postnatal weight gain with the risk of respiratory
symptoms in a cohort of preterm-born children. Furthermore, we
conducted multiple regression analyses and mediation analyses to
identify early-life factors thatmay account for the association between
fetal or infant weight gain and childhood respiratory symptoms. We
hypothesized that change in fetal growth trajectory, or rapid postnatal
weight gain in infancy, would be associated with increased childhood
respiratory symptoms in preterm-born children.
2 | METHODS
2.1 | Respiratory and neurological outcomes of
children born preterm study (RANOPS)
Respiratory outcome data from RANOPS, a cross-sectional population
study of preterm-born children, were used. Briefly, in 2013, all live-born
preterm (<37 weeks’ gestation) surviving children born in Wales aged
between 1 and 10 years, and term controls (born same gender, day, and
locality) were sent the Liverpool Respiratory Symptom Questionnaire
(if <5 years of age) or a modified ISAAC Questionnaire (if ≥5 years of
age), n = 23 722.2 There were 7148/26 741 (27%) responders to the
questionnaire survey (32% in the preterm-born group). Both ques-
tionnaires have been validated.22,23 Data from all responderswere used
in the analyses as we have previously reported similar characteristics
between matched responders and all responders.2 Ethical approval for
the survey was obtained from the Research Ethics Committee and
parents gave consent for use of their data, and for healthcare database
linkage, by returning completed questionnaires.
2.2 | Perinatal data
Gestational age, birthweight, singleton, or multiple birth and Wales
Index of Multiple Deprivation (WIMD, a measure of socio-economic
status) were available from national healthcare databases (NHSWales
Informatics Service, NWIS). Children were divided into groups based
on gestational age at birth: 25-32, 33-34, 35-36 weeks’ gestation and
term controls (37-43 weeks’ gestation). This approach is similar to our
studies on lung function24 and that of others as it represents specific
stages in lung development and children most at risk of lung disease.9
Intrauterine growth restriction (IUGR) was defined as <10th centile for
standardized birthweight corrected for gestation and gender using the
LMS method (Medical Research Council, UK).25
2.3 | Fetal growth data
Antenatal scans were obtained through NWIS for four of seven health
boards inWales who share a common radiology record system. Crown
rump length (CRL), head circumference (HC), and femur length (FL)
were extracted using amethod coded in C++ and checked for accuracy
against the original data. Multiple pregnancies were excluded as
identity of which fetus was scanned at 1st and 2nd trimesters was
uncertain.
Gestation (in completed weeks) was abstracted from the scan
reports where possible, or, if missing, was calculated from the
difference between gestation at birth and scan date. Robinson (CRL)
and Chitty (HC and FL) growth charts were used to create z-scores,
adjusted for gestational age and gender at the time of measurement,
using the published equations.26,27 CRL z-score for 1st trimester scans
closest to 12 weeks’ gestation (10-13 weeks’ gestation, and within
3.5 SD of mean CRL measurement) were identified for each child. For
second trimester scans, HC and FL z-scores closest to 20 weeks’
gestation (17-23 weeks, and within 3.5 SD of mean HC or FL
measurement) were estimated. Growth acceleration was defined as
an increase in fetal measurement of >0.67 SD and growth deceleration
as a decrease of >0.67 SD between each time point (1st trimester to
birthweight and 2nd trimester to birthweight).
2.4 | Infant weight data
Postnatal weight data were provided by NWIS. The weight closest to
9 months of age (limited to 6-12 months) was used to derive z-scores
using the LMS method, as above. Participants with birthweight or
postnatal weight outside ±3.5 SD of the mean, or with unknown
gestational age were excluded.
Infant weight gain between birth and 9months of age was defined
by dichotomizing the population in to those who demonstrated an
increase of >0.67 SD in weight and those who did not, as previously.25
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We also used the method of Royston to calculate measures of
conditional weight velocity between birth and nine months of age.28
2.5 | Respiratory outcome data
Respiratory outcomes were extracted from the RANOPS question-
naires which included wheeze-ever, recent wheeze (last 3 months for
<5 years of age; last 12 months for ≥5 years of age), use of inhalers,
hospital admissions for chest-related problems, and doctor-diagnosed
asthma (≥5 years of age only). All outcomes were dichotomous.2 Rates
of maternal smoking during pregnancy and current smoking were also
taken from the RANOPS questionnaire.
3 | STATISTICAL ANALYSIS
Chi-squared testswereused to investigate thedifferences in categorical
demographic data between datasets used in the fetal growth analysis,
and between weight gain groups (>0.67 SD weight gain or not) in the
infant growth analyses. Normality of continuous data was checked by
visually inspectingQ-Q plots. Independent sample t-testswere used for
normally distributed continuous variables. WIMD score was subse-
quently converted in to quintiles for use in statistical models.
Since every case in the fetal analysis did not have a complete set of
biometric data, we used sub-sets of cases with the appropriate
combination of measurements (eg, CRL and HC). To assess whether
this approach would introduce any bias, we compared the baseline
demographics of each sub-set against the reference set (before exclusion
for missing biometric data) using standardized differences. Then,
univariate logistic regression models were used to investigate the
association between fetal size in the first trimester (CRL) and size in the
2nd trimester (HC and FL) with childhood respiratory outcomes. Further
models then investigated change in growth between 1st trimester
and birth (CRL-Birthweight), between 2nd trimester and birth
(HC-Birthweight and FL-birthweight), and odds of childhood respiratory
outcomes. “No change” was set as the reference category. Confounders
were then included in adjusted multivariable models if they had a P-
value <0.10forassociationwith “wheeze-ever,”whichwas theconsidered
the primary outcome for all analyses. A similar modeling approach was
applied to the infantweight gaindata, usingbothweight gain >0.67 SD (or
not) then conditional weight gain as the primary exposure variables.
Next, we considered the whole cohort population (including
preterm and term groups) and used interaction terms to investigate the
combined effects of gestation groups and infant weight gain when
defined as >0.67 SD change between birthweight and weight at
9 months. Term-born children with “no change” for weight gain were
used as the control category. Both univariate, and multivariable
modeling including covariates with a P-value <0.10, were performed.
All modeling was performed using SPSS (version 20, IBM, Chicago IL).
P < 0.05 was considered statistically significant.
Finally, to assess if the relationship between weight gain and
“wheeze-ever” was mediated through gestational age and
other significant covariates, we performed mediation analysis using
structural equation modeling (Mplus version 7, Muthen and Muthen,
Los Angeles, CA); all potential mediators were entered in parallel.
4 | RESULTS
4.1 | Fetal size and growth patterns
After excluding participants who did not consent for database linkage
or who resided in the three health boards where radiology database
linkage was not possible, 5012/7148 (70%) of participants remained
eligible. Finally, after excluding those with missing maternal demo-
graphic data, 10 428 antenatal ultrasound scans were obtained from
3125/5012 individuals of which 1880 (60%) were born preterm. In
total, 615 CRL, 1,196 HC, and 1,326 FL measurements were available
from preterm-born children (Supplementary Figure S1). When com-
pared to the whole dataset, there were small differences (standardized
differences <0.10) in demographics when alternative fetal measure-
ments were used in the analysis (Supplementary Table S1).
For first trimester CRL size at 12 weeks’ and 2nd trimester HC or
FL at 20 weeks’ gestation, association with childhood respiratory
outcomes were negligible (Supplementary Table S2).
Gestational age, gender, ethnicity, current maternal smoking,
family history of asthma/atopy, breastfeeding, WIMD, and whether
the child was aged over or under 5 years were all statistically
significantly associated with wheeze-ever in univariate analysis
(Supplementary Table S3). When a change of 0.67 SD of z-score
was used to define growth trajectory, accelerated, but not decelerated
growth from 1st trimester CRL to birthweight was associated with
wheeze-ever (acceleration: OR 2.01; 95%CIs 1.25, 2.32; deceleration:
OR 1.32; 95%CIs 0.89, 1.94) in the fully adjusted model when
compared to those with unchanged trajectory (Table 1). Growth
deceleration from 1st trimester CRL to 2nd trimester HC was
associated with increased odds of wheeze-ever (OR 1.59; 95%CI
1.01, 2.51). In contrast, accelerated growth from 2nd trimester HC to
birthweight was associated with increased odds of wheeze-ever (OR
1.60; 95%CIs 1.15, 2.22) (Table 1). The tests of association were
inconclusive (P > 0.05) when FL, rather than HC, were used as the
measure of 2nd trimester size (data not shown).
4.2 | Infant weight gain
Following exclusions for missing birthweight, missing weight at
9 months, and weight z-score ±3.5 SD, 5824/7149 (81%) of
responders to the questionnaire survey had valid data; 3425
participants were born preterm and 2399 were born at term
(Supplementary Figure S1).
Demographics of preterm-born children with, and without weight
gain of >0.67 SD are presented in Supplementary Table S4. Children of
lower birthweight, whose mothers smoked during pregnancy, of lowest
WIMD quintile, and whose mothers currently smoke, were more likely
to exhibit weight gain >0.67 SD between birth and 9 months of age.
Children born with IUGR, delivered by caesarean section, and as one of
multiple birth were also more likely to exhibit weight gain.
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In univariate analysis, increased wheeze-ever was associated with
infantweight gain (OR1.20;95%CI1.03,1.41), lowergestational age,male
gender, maternal smoking in pregnancy, currentmaternal smoking, family
history of asthma/atopy, and lowerWIMD quintile. Non-white ethnicity,
breastfeeding and being ≥5 years of age were associated with decreased
odds ofwheeze-ever (Supplementary Table S5). In the adjustedmodel, an
increase in weight >0.67 SD between birth and 9 months of age was
associated with wheeze-ever in preterm-born children (OR 1.22; 95%CI
1.02, 1.45) (Table 2). All other covariates remained significant aside from
breastfeeding and maternal smoking in pregnancy. Excluding children
frommultiple births did not affect the results (data not shown).When the
cohort was stratified in to those aged <5 years and those aged ≥5 years,
wheeze-ever was significant in the fully adjusted model in ≥5 years age
group only (OR1.37; 95%CI 1.06, 1.77), Table 2. Sensitivity analysis using
conditional growth showed similar results, with marginally attenuated
ORs (Supplementary Table S6).
Compared to term-born children who did not demonstrate weight
gain of >0.67 SD between birth and the age of 9 months, children born
≤32 weeks’ gestation with infant weight gain of >0.67 SD had
increased odds of wheeze-ever (OR 5.04; 95%CI 3.36, 7.54, Figure 1).
Results of the mediation analysis are summarized in Figure 2.
Gestational age, maternal smoking in pregnancy, current maternal
smoking, and breastfeeding all had statistically significant univariate
associations withweight gain; the test for associationwas inconclusive
for gender, being ≥5 years of age, ethnicity and family history of
asthma/atopy. All of these factors were statistically significant
predictors (P < 0.05) of wheeze aside from maternal smoking in
pregnancy. Of the above covariates, bootstrapped confidence
intervals for specific indirect effects did not include zero for gestational
age and current maternal smoking, indicating strong evidence that
weight gain influenced wheeze-ever via gestational age and current
maternal smoking. Moreover, the size of the direct effect (B = 0.07,
P = 0.22) diminished relative to the adjusted regression model
presented in Q7Supplementary Table S5 (B = 0.19, P = 0.03), further
indicating the mediating effect of these two factors.
5 | DISCUSSION
In our cohort of preterm-born children, we have reported that rapid
weight gain in the first year of life is statistically significantly associated
with increased wheeze in childhood. We also noted the interaction
between birth at the extremes of prematurity and postnatal weight
gain resulted in the poorest respiratory outcome (OR 5.04). Using
mediation analysis, we have identified modifiable factors that may
have an important influence on the relationship between weight gain
and childhood respiratory symptoms.We also reported increased odds
for wheeze-ever for fetal growth deceleration between the 1st-2nd
trimester (OR 1.59), and for growth acceleration between the 2nd
trimester and birth (OR 1.60).
5.1 | Fetal growth
Previous studies in term-born cohorts have used birthweight as proxy
for fetal growth and examined associations with respiratory outcomes,
with mixed results.29,30 By assessing growth over gestational ranges,
we have attempted to investigate the impact of growth trajectory in
preterm-born children during key periods of development.
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TABLE 1 Association Q4between fetal growth trajectories and respiratory symptoms in preterm-born children
Wheeze-ever Recent wheeze Inhaler use Hospital admission
1st trimester CRL to birthweight
Preterm all measurements N = 615 (adjusted)a
Deceleration N = 306 1.32 (0.89, 1.94) 1.00 (0.65, 1.54) 0.71 (0.45, 1.13) 0.80 (0.39, 1.64)
Acceleration N = 142 2.01* (1.25, 2.32) 1.42 (0.86, 2.34) 1.35 (0.81, 2.26) 1.70 (0.78, 3.70)
No change N = 167 Ref Ref Ref Ref
1st trimester CRL to 2nd trimester HC
Preterm all measurements N = 615 (adjusted)a
Deceleration N = 306 1.59* (1.01, 2.51) 1.29 (0.79, 2.11) 1.60 (0.94, 2.70) 3.84* (1.56, 9.51)
Acceleration N = 142 1.07 (0.70, 1.62) 0.94 (0.59, 1.50) 1.00(0.60, 1.66) 2.57* (1.08, 6.09)
No change N = 167 Ref Ref Ref Ref
2nd trimester HC to birthweight
Preterm all measurements N = 1196 (adjusted)a
Deceleration N = 486 1.24 (0.95, 1.62) 0.94 (0.74, 1.26) 0.95 (0.70, 1.31) 0.92 (0.58, 1.46)
Acceleration N = 238 1.60* (1.15, 2.22) 1.39 (0.99, 1.96) 1.22 (0.84, 1.77) 1.39 (0.23, 2.34)
No change N = 472 Ref Ref Ref Ref
Data Q5are odds ratios (95% confidence intervals).
*P < 0.05.
aAdjusted for gestational age, gender, ethnicity, currentmaternal smoking, family historyof asthma/atopy, breastfeeding,WIMD, andchild<5or≥5yearsof age.
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Three groups have investigated similar hypotheses to ours, all of
which were conducted in term-born cohorts. In common with our
study, theGeneration-R cohort did not detect any association between
fetal size and childhood respiratory outcomes in early childhood.14 In
contrast, Turner and colleagues reported decreased odds for
respiratory symptoms and improved lung function per millimeter
increase in fetal measurement in term-born children at 5 and 10 years
of age.12,13The mechanisms of how change in growth rate impacts
upon the developing organs are not yet known, however, the main
structures of the respiratory system are established by the early
second trimester, whereas differentiation and maturation occur
between the 2nd trimester and birth.31 One possibility is that
structural deficits established early in gestation manifest later as
airway obstruction due to smaller airways. For example, growth
faltering between the 1st and 2nd trimesters was statistically
significantly associated with increased respiratory symptoms in the
Aberdeen cohort.32 Our results also noted that growth deceleration
between the 1st and 2nd trimester was associatedwith increased odds
of wheeze-ever (OR 1.59 95%CI 1.01, 2.51). An interesting finding
within the Southampton cohort was that growth faltering between the
1st and 2nd trimester was also linked to non-atopic wheeze, whereas
faltering between second to third trimesters was statistically
significantly associated with atopic wheeze.11 The authors speculate
this may relate to altered immunological status. To date, the RANOPS
cohort does not have any direct data on atopic status (ie, results of skin
prick testing); however, family history of atopy was abstracted from
the questionnaire. Although family history was strongly related to
respiratory outcomes in univariate analysis, it was not significant in the
statistical analysis performed when modeling with measures of foetal
growth change. This is in keeping with the primary analysis of the
RANOPS cohort which established that “prematurity-associated
wheeze” phenotype is unlikely to include atopy as one of its
determinants.2 In our results, acceleration from the 2nd to 3rd
trimester was statistically significantly associated with wheeze-ever.
This has not been widely reported in respiratory studies, although the
latter Aberdeen study reported increased asthmawith current wheeze
for growth acceleration between the first and second trimesters, when
compared to the reference category of consistently high growth.12
Moreover, growth acceleration has been noted to be a risk factor for
early adiposity gain at 6months33 and 3 years of age.34 These potential
adverse effects of both growth restraint and growth acceleration are
consistent with the “predictive adaptive response,” whereby altered
fetal growth may dispose the infant to a developmental mismatch with
the postnatal environment.7
5.2 | Postnatal weight gain in preterm-born children
Few studies in preterm-born cohorts have investigated the association
between early weight gain in infancy and respiratory health in
childhood and adolescence. A study of the NINFEA cohort demon-
strated that rapid growth velocity was a significant predictor of
increased wheeze during the first 18 months of life in term-born
infants.17 Two recent studies in term-born children reported
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decrements in lung function and increased respiratory symptoms at
age 5 when rapid postnatal growth was observed between birth and
3 months of age, the latter of which was independent of fetal
growth.14,18 Both the Southampton and Aberdeen groups noted that
early childhood wheeze at age 3 was statistically significantly
associated with weight gain throughout the first year of life.13,35
The report by Belfort noted an association between asthma at the age
of 8 years and postnatal growth in preterm infants.36 This was not
compensated by increased linear growth, indicating the potential
developmental mismatch between somatic and organ growth which
may promote later obesity and lung disease, possibly through the pro-
inflammatory immunological effects.37
Other studies in term-born cohorts have investigated longer
periods over which to define weight gain and noted increased
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FIGURE 1 Graphical representation of interaction analysis (adjusted). All ORs for wheeze-ever are compared to the reference category of
Term-born, no change in weight gain between birth and 9 months of age (* P < 0.05 compared to reference category). Error bars represent
95% confidence intervals for ORs
FIGURE 2 Diagrammatic representation of mediation analysis results in preterm-born children
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respiratory infections in the first years of life,16 asthma in school-age
children,19,38 and decreased measures of peripheral airway flow in
adolescence.15 Along with our data in preterm-born children, these
studies further support the concept that rate of weight gain is an
important factor in influencing later respiratory health, possibly
because the airways may be small in comparison to lung capacity
(dysanapsis). Further data on lung function complement this hypothe-
sis.39 We repeated our analysis using weight data at 24 months, and
failed to detect associations with respiratory symptoms (data not
shown). Methodological differences in calculating weight gain may be
responsible for these differences, however, one possibility is that the
deleterious effects of early weight gain on respiratory health may be
mitigated if “catch-up” lung growth occurs over a longer period of time.
Our previous data suggest that deficits in FEV1 present in IUGR term-
born children are ameliorated by catch-up growth by 8 years of age.25
Similar to others,20 we observed an incremental increase in odds of
wheeze-ever for decreasing gestational agewith infantweight gain,when
compared to a term-born control growth without weight gain (OR 5.04).
Weextendedour findingsby identifyingcurrentmaternal smoking, aswell
as gestation, as a mediator of the relationship between weight gain and
wheeze-ever in preterm-born children. Maternal smoking can be
considered a proxy of socio-economic status and may represent higher
rates of formula feeding.40 Thus, nutrition may be key in balancing the
beneficial effects of growth versus potential harmof excessweight gain in
preterm-born infants.Exclusivebreastfeedingameliorated theassociation
between postnatal weight gain and increased early transient wheeze in
term-born children in the study by Turner et al.32
5.3 | Strengths and limitations
In commonwithmany cohort studies, themain limitation of ourwork is
the attrition of cases available for analysis due to non-response to the
questionnaire survey, absence of consent for data linkage, and
challenges with database accessibility. Moreover, we cannot rule
out residual confounding in our data by unmeasured covariates. We
conducted an additional sensitivity analysis by modeling wheeze-ever
on the interaction between each variable in our final model with infant
weight gain. The results indicated that weight gain may have a
differential effect in certain sub-groups (eg, gender), Supplementary
Table S7. Another limitation of our study is its use of an exploratory
approach to model-building and the lack of overall control for
the multiplicity of hypothesis tests which involved multiple outcome
variables, multiple definitions of the exposure variables, and multiple
inclusion criteria (eg, subgroups). Thus, some results may have
occurred by chance and this must be considered when interpreting
the data. In the cohort at-large, non-responders to the questionnaire
were of lower socio-economic status.2 However, given that infants
born into such conditions aremore likely to be born preterm, IUGR and
have been exposed to a less favorable intrauterine growth environ-
ment, we conjecture that inclusion of these children might have
strengthened the associations we have observed.
Themain strengthof our study is the useof a contemporary cohort of
preterm-born children for exploration of growth patterns and exposures
that may be risk factors for wheezing symptoms in childhood. We used
well-established, validated questionnaires; this allows comparison with
other studies. Moreover, we were able to link to national databases to
obtain both antenatal and postnatalmeasurements for themajority of the
cohort who provided respiratory symptom data; however, we were
limited to only routinely collected data. The sample sizes and numbers of
non-missing values varied across themeasured predictors and outcomes.
Some cases had valid fetal data only, whereas some had valid postnatal
data only, and as such different cases were included in the two analyses.
Data were obtained retrospectively; we acknowledge that prospective
collectionofdatamayhave improved theaccuracyof the results and there
will be some variation due to differences between equipment and use by
the operator. Notwithstanding, we used two methods of defining weight
gain and obtained similar results.
6 | CONCLUSION
In conclusion, our study suggests that antenatal and postnatal growth
rates are important for future respiratory health in preterm-born children.
Since they are unlikely to have the same etiology of lung disease as their
term-born peers, it is important to consider strategies for ensuring
appropriate growth. Optimizing nutrition in the neonatal period and
diminishing exposure to environmental pollutants, such as anti-and-
postnatal tobacco smoking, present two potential interventions.
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